Biotransformation of 7, 12-dimethylbenz(a)anthracene(DMBA): on the genesis of DMBA-trans-dihydrodiols and DMBA-7- and 12-methylhydroxylated metabolites.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000031:analogs & derivatives / Q000378:metabolism*; D000818:Animals; D001551:Benz(a)Anthracenes / Q000378:metabolism*; D001571:Benzoflavones; D002246:Carbon Disulfide / Q000494:pharmacology; D005419:Flavonoids / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D013058:Mass Spectrometry; D008748:Methylcholanthrene / Q000494:pharmacology; D008797:Metyrapone / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship; D019324:beta-Naphthoflavone
D001551:Benz(a)Anthracenes; D001571:Benzoflavones; D005419:Flavonoids; D008748:Methylcholanthrene; C024976:12-hydroxymethyl-7-methylbenz(a)anthracene; C018970:7-hydroxymethyl-12-methylbenz(a)anthracene; D015127:9,10-Dimethyl-1,2-benzanthracene; C011512:alpha-naphthoflavone; D019324:beta-Naphthoflavone; D011335:Proadifen; D002246:Carbon Disulfide; D010634:Phenobarbital; D008797:Metyrapone